Prodrugs in Genetic Chemoradiotherapy
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2131-2154
Author(s):
Adam V. Patterson, Mark P. Saunders and Olga Greco
Tumor Escape from Immune Response: Mechanisms and Targets of Activity
Journal:
Current Drug Targets
Volume:
4
Page:
525-536
Author(s):
Dmitry Gabrilovich and Vladimir Pisarev
Is HIV Involved in the Pathogenesis of Non-Infectious Pulmonary Complications in Infected Patients?
Journal:
Current HIV Research
Volume:
1
Page:
385-393
Author(s):
Georgette D. Kanmogne, Ronald C. Kennedy and Paula Grammas
Immune Response Manipulation: Recombinant Immunoreceptors Endow T-Cells with Predefined Specificity
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1992-2001
Author(s):
Hinrich Abken, Andreas Hombach and Claudia Heuser
Chemistry of Bis-Spiroacetal Systems: Natural Products, Synthesis and Stereochemistry
Journal:
Current Organic Chemistry
Volume:
7
Page:
1461-1484
Author(s):
Margaret A. Brimble and Daniel P. Furkert
Anti-Epidermal Growth Factor Receptor Strategies to Enhance Radiation Action
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
327-333
Author(s):
G. Lammering
Hypoxic Radiosensitizers and Hypoxic Cytotoxins in Radiation Oncology
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
364-374
Author(s):
Martin Weinmann, Stefan Welz and Michael Bamberg
Molecular Targets for Papillomavirus Therapy
Journal:
Current Drug Targets - Infectious Disorders
Volume:
3
Page:
221-239
Author(s):
V. G. Wilson and G. Rosas-Acosta
Radiation and Gene Therapy: Rays of Hope for the New Millennium?
Journal:
Current Gene Therapy
Volume:
3
Page:
319-339
Author(s):
M. Boyd, H. S. Spenning and R. J. Mairs
The HAG Mechanism: A Molecular Rationale For The Therapeutic Application Of Iron Chelators In Human Diseases Involving the 2-Oxoacid Utilizing Dioxygenases
Journal:
Current Medicinal Chemistry
Volume:
10
Page:
1005-1019
Author(s):
Hartmut M. Hanauske-Abel and Anthony M. Popowicz